SCHEDULE 13G 0001603466 XXXXXXXX LIVE Common Stock, par value $0.0001 per share 05/29/2025 0001796280 Oric Pharmaceuticals, Inc. 68622P109 240 E. GRAND AVE. 2ND FLOOR South San Francisco CA 94080 Rule 13d-1(c) Point72 Asset Management, L.P. b DE 0.00 4401659.00 0.00 4401659.00 4401659.00 N 5.1 PN Includes 1,923,107 Shares (as defined in Item 2(a)) issuable upon exercise of warrants. Point72 Capital Advisors, Inc. b DE 0.00 4401659.00 0.00 4401659.00 4401659.00 N 5.1 CO Includes 1,923,107 Shares issuable upon exercise of warrants. Steven A. Cohen b X1 0.00 4401659.00 0.00 4401659.00 4401659.00 N 5.1 IN Includes 1,923,107 Shares issuable upon exercise of warrants. Oric Pharmaceuticals, Inc. 240 E. Grand Ave, 2nd Floor, South San Francisco, CA, 94080 This statement is filed by: (i) Point72 Asset Management, L.P. ("Point72 Asset Management") with respect to the shares of common stock, par value $0.0001 per share ("Shares"), of ORIC Pharmaceuticals, Inc. (the "Issuer") held by (and Shares issuable upon exercise of the warrants held by) Point72 Associates, LLC, an investment fund it manages ("Point72 Associates"); (ii) Point72 Capital Advisors, Inc. ("Point72 Capital Advisors Inc.") with respect to Shares held by (and Shares issuable upon exercise of the warrants held by) Point72 Associates; and (iii) Steven A. Cohen ("Mr. Cohen") with respect to Shares beneficially owned by Point72 Asset Management and Point72 Capital Advisors Inc. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 99.1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Securities Exchange Act of 1934 (the "Act"). The address of the principal business office of Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen is 72 Cummings Point Road, Stamford, CT 06902. Point72 Asset Management is a Delaware limited partnership. Point72 Capital Advisors Inc. is a Delaware corporation. Mr. Cohen is a United States citizen. Y The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on June 3, 2025. Point72 Asset Management, Point72 Capital Advisors Inc., and Mr. Cohen own directly no Shares. Pursuant to an investment management agreement, Point72 Asset Management maintains investment and voting power with respect to the securities held by Point72 Associates. Point72 Capital Advisors Inc. is the general partner of Point72 Asset Management. Mr. Cohen controls each of Point72 Asset Management and Point72 Capital Advisors Inc. The filing of this statement should not be construed as an admission that any of the foregoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the Shares reported herein. The aggregate percentage of the Shares reported to be beneficially owned by each Reporting Person as of June 3, 2025, is based on 87,141,500 Shares outstanding, which is the sum of: (i) 71,088,080 Shares outstanding as of April 28, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission (the "SEC") on May 5, 2025, (ii) 14,130,313 Shares issued upon the closing of a private placement on May 29, 2025, as disclosed in the Issuer's Current Report on Form 8-K filed with the SEC on May 28, 2025, and (iii) 1,923,107 Shares issuable upon the exercise of the warrants reported herein. 5.1% The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on June 3, 2025. The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on June 3, 2025. The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on June 3, 2025. The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference. Such information is as of the close of business on June 3, 2025. Y N Point72 Associates has the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding Shares. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. Exhibit 99.1: Joint Filing Agreement Point72 Asset Management, L.P. /s/ Jason M. Colombo 06/04/2025 Point72 Capital Advisors, Inc. /s/ Jason M. Colombo 06/04/2025 Steven A. Cohen /s/ Jason M. Colombo 06/04/2025